Home/Filings/4/0001562180-20-001246
4//SEC Filing

Kanes Stephen 4

Accession 0001562180-20-001246

CIK 0001597553other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:57 PM ET

Size

7.7 KB

Accession

0001562180-20-001246

Insider Transaction Report

Form 4
Period: 2020-02-12
Kanes Stephen
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-02-12+17,50017,500 total
    Exercise: $68.87Exp: 2030-02-12Common Stock (17,500 underlying)
Footnotes (1)
  • [F1]The securities awarded on February 12, 2020 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 4,375 shares of common stock shall vest on the one year anniversary of February 12, 2020, with 13,125 shares vesting in 36 equal monthly installments thereafter.

Issuer

Sage Therapeutics, Inc.

CIK 0001597553

Entity typeother

Related Parties

1
  • filerCIK 0001612859

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:57 PM ET
Size
7.7 KB